about
Discovering potent inhibitors against the beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Helicobacter pylori: structure-based design, synthesis, bioassay, and crystal structure determination(+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant MiceDesign, synthesis, and pharmacological evaluation of monocyclic pyrimidinones as novel inhibitors of PDE5The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung CancerCatalytic mechanism investigation of lysine-specific demethylase 1 (LSD1): a computational studyAST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits antitumor activity both in vitro and in vivoPrediction of cancer drugs by chemical-chemical interactionsMechanism of the All-α to All-β Conformational Transition of RfaH-CTD: Molecular Dynamics Simulation and Markov State Model.Water PMF for predicting the properties of water molecules in protein binding site.In Silico target fishing: addressing a "Big Data" problem by ligand-based similarity rankings with data fusion.Integrated Analysis of Multiscale Large-Scale Biological Data for Investigating Human Disease 2016An effective docking strategy for virtual screening based on multi-objective optimization algorithm.Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.Catalytic mechanism of histone acetyltransferase p300: from the proton transfer to acetylation reactionEstimation of acute oral toxicity in rat using local lazy learningMetadynamics simulation study on the conformational transformation of HhaI methyltransferase: an induced-fit base-flipping hypothesisAn integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties.Molecular basis of NDM-1, a new antibiotic resistance determinantNovel Bayesian classification models for predicting compounds blocking hERG potassium channels.Computational screening for active compounds targeting protein sequences: methodology and experimental validation.A triad of lys12, lys41, arg78 spatial domain, a novel identified heparin binding site on tat protein, facilitates tat-driven cell adhesion.Toward understanding the molecular basis for chemical allosteric modulator design.Identification of novel small molecules as inhibitors of hepatitis C virus by structure-based virtual screening.Rapid generation of privileged substructure-based compound libraries with structural diversity and drug-likeness.Prediction of drug indications based on chemical interactions and chemical similarities.Virtual screening and biological evaluation of novel small molecular inhibitors against protein arginine methyltransferase 1 (PRMT1).TarPred: a web application for predicting therapeutic and side effect targets of chemical compounds.Integrated analysis of multiscale large-scale biological data for investigating human disease.[Diversity-oriented synthesis and its application in drug discovery].Combinatorial Pharmacophore-Based 3D-QSAR Analysis and Virtual Screening of FGFR1 Inhibitors.Combinatorial Pharmacophore Modeling of Multidrug and Toxin Extrusion Transporter 1 Inhibitors: a Theoretical Perspective for Understanding Multiple Inhibitory MechanismsIdentification of compound-protein interactions through the analysis of gene ontology, KEGG enrichment for proteins and molecular fragments of compounds.A Genetic Algorithm Based Support Vector Machine Model for Blood-Brain Barrier Penetration Prediction.Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4.Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors.Identification of novel candidate drivers connecting different dysfunctional levels for lung adenocarcinoma using protein-protein interactions and a shortest path approachPrediction of effective drug combinations by chemical interaction, protein interaction and target enrichment of KEGG pathways.Computational models for predicting interactions with membrane transporters.Non-covalent interactions with aromatic rings: current understanding and implications for rational drug design.Computational methods for drug design and discovery: focus on China.
P50
Q27654259-54D93C2F-A8BC-4551-B681-23FC1E8A1F69Q27677636-FA584509-EBC9-4E5F-9283-8AB498E7C1C4Q27683287-A72FD73A-168E-40AF-9A0B-5AC4793497B6Q28395836-42FA7D89-FDAD-4F42-B9B3-08B43E8CDD9CQ28477309-D7ED9B95-5F13-4E99-8145-0379F47F91D7Q28479059-B107E4FC-CF56-4EA6-8B4A-2957BA6D36CCQ28539449-4A4005BD-E891-490E-B60B-B2386D76A585Q30153389-FBD32C7D-05E6-469A-9E5B-83465B400CFFQ30423037-4B4065D0-7F27-4554-95B1-DD9F2F3CAF6CQ30833986-811FF128-18E5-412C-BAAC-51F0F3527A00Q31134811-401B3D7C-CC73-4291-838B-4C37727DE60FQ33408373-E23D7954-3DB2-4059-816B-5FA465D08A3AQ33635671-F5E24F72-11FC-43D7-A7BA-32DBA3AB79E3Q33679805-42381375-BD5D-40A3-9325-3552D7C9FC0BQ33719719-7A733265-9315-4E50-BD31-340BB94CC8EDQ33876474-92890EAA-A353-498E-81D3-C2872385AF3DQ33888168-FC0E3D9B-9D2C-447E-ACAD-97AABE28170DQ34009443-9DDED337-77A8-4852-BCF1-C121C80022D3Q34017962-EC21DFD6-0F16-412A-8B97-67D39F2C99B6Q34033809-B0A5AF03-D4C6-40AB-BF9F-41016E10F284Q34197864-8DE9EE73-C86A-4FD5-AB86-F65D82D7B6A2Q34453288-1BBBB999-24F7-4A06-870F-43CAE7702923Q35050116-D881676F-A91E-491C-96AC-36EAD482AD5EQ35093954-029C1DC4-7406-4F05-BAE1-42B5D84036D9Q35187910-E510BB32-35DB-4718-B24B-DE8E8801D552Q35369909-34D19C15-C14F-45BA-B204-3AE11C49D62EQ35562182-623E868B-E0C4-4F4C-B391-ADBF37F4C5DFQ35631293-D223F70E-AF9C-4C64-AF91-343CA4ED3F53Q35724179-CE369129-3C6F-4371-818F-F22600A466C1Q35814029-CDD5BDAC-1A5A-43E8-AD7C-AF17796F06CFQ36017868-98F5CBFE-C8EA-4ED9-8B31-89043AEDE1C6Q36105215-853B3BAE-93D9-4A2A-B830-93396A01AD00Q36172940-3ABC346F-2537-4A54-B122-6DFC33B2A588Q36411267-08D2156A-F014-4F5D-8A9B-43CB1A2AC2F5Q36872149-C38A7655-30F3-4720-B9E2-CD8CE6785959Q37093141-F9B56BF4-53B4-4171-AC09-2588469BCE47Q37191078-A635642A-9536-4B6E-99C0-5BE3B89D9E62Q38081483-C4B5A287-D5E8-4EF4-93F9-C0ED6EA29161Q38114908-7FC367EF-0717-4750-935D-176D7F70FB1CQ38137563-A736E937-F6BA-4648-A8DD-D6541B46DE78
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mingyue Zheng
@ast
Mingyue Zheng
@en
Mingyue Zheng
@es
Mingyue Zheng
@nl
Mingyue Zheng
@sl
type
label
Mingyue Zheng
@ast
Mingyue Zheng
@en
Mingyue Zheng
@es
Mingyue Zheng
@nl
Mingyue Zheng
@sl
prefLabel
Mingyue Zheng
@ast
Mingyue Zheng
@en
Mingyue Zheng
@es
Mingyue Zheng
@nl
Mingyue Zheng
@sl
P1053
B-4860-2010
P106
P2456
P31
P3829
P496
0000-0002-3323-3092